A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Clinical trial NCT06143046 · COMPLETED

Trial details

NCT number: NCT06143046
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus

Start date: 2023-11-15
Primary completion: 2026-05-25
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.